Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (2): 29-34.doi: 10.6040/j.issn.1671-7554.0.2018.1327

Previous Articles    

Research progress of fertility preservation methods

RUAN Xiangyan1, CHENG Jiaojiao1, DU Juan1, LI Yanglu1, JIN Fengyu1, Alfred O. MUECK1,2   

  1. 1. Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
    2. Section of Endocrinology and Menopause, Department of Womens Health, University of Tuebingen, Tuebingen 72076, Baden-Württemberg, Germany
  • Published:2022-09-27

PDF (PC)

86

Abstract: With the development of antineoplastic treatments, the survival rate of cancer patients has been greatly improved, and fertility preservation has been put on more and more attention from doctors and patients, especially with the sub-discipline of oncofertility. With the improvement of modern living standards, womens reproductive age is postponed and there is a great demand for fertility preservation. Oocytes cryopreservation and embryos cryopreservation are common methods of fertility preservation. Ovarian tissue cryopreservation is no longer a pilot technique in developed countries. This article mainly describes the indications of fertility preservation and the progress of commonly used fertility preservation methods.

Key words: Fertility preservation, Ovarian tissue cryopreservation, Embryo cryopreservation, Oocyte cryopreservation, Oncofertility

CLC Number: 

  • R711.75
[1] Donnez J, Dolmans MM. Fertility preservation in women[J]. N Engl J Med, 2018, 378(4): 400-401.
[2] Dolmans MM. Recent advances in fertility preservation and counseling for female cancer patients[J]. Expert Rev Anticancer Ther, 2018, 18(2): 115-120.
[3] De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer[J]. Lancet, 2014, 384(9950): 1302-1310.
[4] Yasmin E, Balachandren N, Davies MC, et al. Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline.[J]. Human fertility(Cambridge, England), 2018, 21(1):3-26.
[5] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[6] Letourneau JM, Melisko ME, Cedars MI, et al. A changing perspective: improving access to fertility preservation[J]. Nat Rev Clin Oncol, 2011, 8(1): 56-60.
[7] Algarroba GN, Sanfilippo JS, Valli-Pulaski H. Female fertility preservation in the pediatric and adolescent cancer patient population[J]. Best Pract Res Clin Obstet Gynaecol, 2018, 48: 147-157. doi:10.1016/j.bpobgyn.2017.10.009.
[8] Anderson RA, Mitchell RT, Kelsey TW, et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults[J]. Lancet Diabetes Endocrinol, 2015, 3(7): 556-567.
[9] Sänger N, Jarisch A, Ochsendorf F, et al. Fertilitätserhalt bei präpubertären und pubertären Kindern und Jugendlichen[J]. Klin Padiatr, 2018, 230(3): 122-129.
[10] 程姣姣, 阮祥燕, 李扬璐, 等. 北京及周边地区早发性卵巢功能不全的病因学研究[J]. 首都医科大学学报, 2018,39(4):494-498. CHENG Jiaojiao, RUAN Xiangyan, LI Yanglu, et al. Etiology of premature ovarian insufficiency in Beijing and surrounding areas[J]. Journal of Capital Medical University, 2018, 39(4): 494-498.
[11] 陈子江, 田秦杰, 乔杰, 等. 早发性卵巢功能不全的临床诊疗中国专家共识[J]. 中华妇产科杂志, 2017, 52(9): 577-581.
[12] Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte[J]. Hum Reprod, 2003, 18(1): 117-121.
[13] Meirow D, Biederman H, Anderson RA, et al. Toxicity of chemotherapy and radiation on female reproduction[J]. Clin Obstet Gynecol, 2010, 53(4): 727-739.
[14] Logan S, Perz J, Ussher J, et al. Clinician provision of oncofertility support in cancer patients of a reproductive age: a systematic review[J]. Psychooncology, 2018, 27(3): 748-756.
[15] Oktay K, Harvey BE, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update summary[J]. J Oncol Pract, 2018, 14(6): 381-385.
[16] Gorman JR, Malcarne VL, Roesch SC, et al. Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns[J]. Breast Cancer Res Treat, 2010, 123(2): 477-485.
[17] Hariton E, Bortoletto P, Cardozo ER, et al. The role of oncofertility clinics in Facilitating access to reproductive specialists[J]. J Patient Exp, 2016, 3(4): 131-136.
[18] Grynberg M, Bidet M, Benard J, et al. Fertility preservation in Turner syndrome[J]. Fertil Steril, 2016, 105(1): 13-19.
[19] Kitajima M, Dolmans MM, Donnez O, et al. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas[J]. Fertil Steril, 2014, 101(4): 1031-1037.
[20] Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2012, 97(9): 3146-3154.
[21] Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline[J]. Lancet, 2014, 384(9950): 1311-1319.
[22] Ter Keurst A, Boivin J, Gameiro S. Womens intentions to use fertility preservation to prevent age-related fertility decline[J]. Reprod Biomed Online, 2016, 32(1): 121-131.
[23] 国际妇科内分泌学会中国妇科内分泌学分会及共识专家. 卵巢组织冻存与移植中国专家共识[J]. 中国临床医生杂志, 2018, 46(4): 496-500. Writing Group of Chinese Society of Gynecological Endocrinology affiliated to International Society of Gynecological Endocrinology(CSGE -ISGE)and Expert Consensus group. Ovarian Tissue Cryopreservation and Transplantation: the First Chinese Expert Consensus[J]. Chinese Journal for Clinicians, 2018, 46(4): 496-500.
[24] Wallace WH, Kelsey TW, Anderson RA. Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation[J]. Fertil Steril, 2016, 105(1): 6-12.
[25] Demeestere I, Simon P, Dedeken L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood[J]. Hum Reprod, 2015, 30(9): 2107-2109.
[26] Wallace WH, Smith AG, Kelsey TW, et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation[J]. Lancet Oncol, 2014, 15(10): 1129-1136.
[27] van den Heuvel-Eibrink MM, van der Kooi ALF, Wallace WHB. Fertility preservation in women[J]. N Engl J Med, 2018, 378(4): 399-400.
[28] Ruan XY. Chinese society of gynecological endocrinology affiliated to the international society of gynecological endocrinology guideline for ovarian tissue cryopreservation and transplantation[J]. Gynecological Endocrinology, 2018: 1-6. doi:10.1080/09513590.2018.1488957.
[29] 阮祥燕, 杜娟, 李扬璐, 等. 冻存卵巢组织移植成功——首次报道[J]. 中华生殖与避孕杂志, 2018,38(9):724-729. RUAN Xiangyan, DU Juan, LI Yanglu, et al. Successful auto-transplantation of frozen-thawed ovarian tissue reported for the first time[J]. Chin J Reprod Contracep, 2018, 38(9): 724-729.
[30] 李扬璐, 阮祥燕, Alfred O.Mueck. 人卵巢组织冻存与移植研究进展[J]. 首都医科大学学报, 2017, 38(4): 485-491. LI Yanglu, RUAN Xiangyan, ALFRED O.mueck. Progress in human ovarian tissue cryopreservation and transplantation[J]. Journal of Capital Medical University, 2017, 38(4): 485-491.
[31] Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue[J]. Lancet, 2004, 364(9443): 1405-1410.
[32] Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy[J]. N Engl J Med, 2005, 353(3): 318-321.
[33] von Wolff M, Dittrich R, Liebenthron J, et al. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women[J]. Reprod Biomed Online, 2015, 31(5): 605-612.
[34] Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases[J]. Hum Reprod, 2017, 32(5): 1046-1054.
[35] Meirow D, Raanani H, Shapira M, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria[J]. Fertil Steril, 2016, 106(2): 467-474.
[36] 阮祥燕, 杜娟, 卢丹, 等. 中国首例冻存卵巢组织移植报告[J]. 首都医科大学学报, 2016, 37(6): 840-842
[37] Ruan X, Du J, Korell M, et al. Case report of the first successful cryopreserved ovarian tissue retransplantation in China[J]. Climacteric, 2018, 21(6): 1-4.
[38] von Wolff M, Germeyer A, Liebenthron J, et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques[J]. Arch Gynecol Obstet, 2018, 297(1): 257-267.
[39] Suzuki N. Ovarian tissue cryopreservation using vitrification and/or in vitro activated technology[J]. Hum Reprod, 2015, 30(11): 2461-2462.
[40] Broer SL, Broekmans FJ, Laven JS, et al. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications[J]. Hum Reprod Update, 2014, 20(5): 688-701.
[41] Van der Ven H, Liebenthron J, Beckmann M, et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates[J]. Hum Reprod, 2016, 31(9): 2031-2041.
[42] Poirot C, Abirached F, Prades M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue[J]. Lancet, 2012, 379(9815): 588.
[43] Ernst E, Kjærsgaard M, Birkebæk NH, et al. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue[J]. Eur J Cancer, 2013, 49(4): 911-914.
[44] Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature[J]. J Assist Reprod Genet, 2013, 30(1): 11-24.
[45] Donnez J, Dolmans MM, Diaz C, et al. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application[J]. Fertil Steril, 2015, 104(5): 1097-1098.
[46] Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy[J]. Hum Reprod, 2013, 28(11): 2996-2999.
[47] von Wolff M, Capp E, Jauckus J, et al. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 199: 146-149. doi:10.1016/j.ejogrb.2016.02.006.
[48] Cakmak H, Katz A, Cedars MI, et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation[J]. Fertil Steril, 2013, 100(6): 1673-1680.
[49] Donnez J, Dolmans MM. Fertility preservation in women[J]. Nat Rev Endocrinol, 2013, 9(12): 735-749.
[50] Rienzi L, Gracia C, Maggiulli R, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance[J]. Hum Reprod Update, 2017, 23(2): 139-155.
[51] Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer[J]. J Clin Endocrinol Metab, 2016, 101(4): 1364-1371.
[52] Hwang JH, Yoo HJ, Park SH, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with(postoperative or primary)pelvic radiotherapy[J]. Fertil Steril, 2012, 97(6): 1387-1393.
[53] Xu M, Pavone ME, Woodruff T. Fruitful progress to fertility: preserving oocytes from chemodestruction[J]. Nat Med, 2011, 17(12): 1562-1563.
[54] Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol, 2013, 31(19): 2500-2510.
[55] Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion[J]. Fertil Steril, 2013, 100(5): 1224-1231.
[56] Demeestere I, Brice P, Peccatori F A, et al. No evidence for the benefit of Gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial[J]. J Clin Oncol, 2016, 34(22): 2568-2574.
[1] HAO Guimin, LUO Zhuoye, WANG Yizhuo. Ethical issues and considerations in fertility preservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 47-52.
[2] LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46.
[3] LU Qun, ZHAO Lulu. Progress on assisted reproductive technology for women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertilitysparing treatment [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 35-41.
[4] YAN Lei, YUE Caixin, LIU Yichun. Fertility preservation in patients with endometriosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 31-34.
[5] MA Xiang, ZHAO Feiyan. Status and progress of oocyte cryopreservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 19-23.
[6] SHI Yuhua, PAN Ye, XIE Yanqiu. Latest advances of embryo cryopreservation technology [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 12-18.
[7] WU Ruifang, LI Changzhong. Status and progress of female fertility protection [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 1-7.
[8] RUAN Xiangyan, CHENG Jiaojiao, DU Juan, GU Muqing. Ovarian tissue cryopreservation and preservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 24-30.
[9] ZHU Xuli, ZHOU Liang, WANG Yue, SUN Qingyun, CAO Mingya, DU Yuanjie, CAO Jinfeng, ZHAO Zhiming, HAO Guimin. Correlation analysis of freezing methods with different sperm sources and pregnancy outcomes [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 86-93.
[10] ZHOU Huimei, YANG Jiaxin, CAO Dongyan, SHEN Keng, XIANG Yang, WU Ming, PAN Lingya, HUANG Huifang, LANG Jinghe. Fertility-sparing radical trachelectomy for young women with early stage cervical cancer: surgical and obstetrical outcomes [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 18-22.
[11] CAO Dongyan, BI Xiaoning, SHEN Keng. Application of anti-Mullerian hormone in gynecologic oncology [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 8-12.
[12] CHEN Shiling, ZHOU Xingyu. Clinical research advances on premature ovarian insufficiency [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 1-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd